Hartford Financial Management’s Matinas BioPharma MTNB Stock Holding History

Hartford Financial Management’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50	Closed	-$541	–	394
2023 Q4	$541	Hold	50	–	–	﹤0.01%	386
2023 Q3	$325	Hold	50	–	–	﹤0.01%	388
2023 Q2	$900	Hold	50	–	–	﹤0.01%	360
2023 Q1	$1.18K	Hold	50	–	–	﹤0.01%	363
2022 Q4	$1.25K	Hold	50	–	–	﹤0.01%	358
2022 Q3	$2K	Hold	50	–	–	﹤0.01%	356
2022 Q2	$2K	Hold	50	–	–	﹤0.01%	361
2022 Q1	$2K	Hold	50	–	–	﹤0.01%	369
2021 Q4	$3K	Hold	50	–	–	﹤0.01%	341
2021 Q3	$3K	Hold	50	–	–	﹤0.01%	363
2021 Q2	$2K	Hold	50	–	–	﹤0.01%	366
2021 Q1	$3K	Hold	50	–	–	﹤0.01%	365
2020 Q4	$3K	Hold	50	–	–	﹤0.01%	325
2020 Q3	$2K	Hold	50	–	–	﹤0.01%	310
2020 Q2	$2K	Hold	50	–	–	﹤0.01%	325
2020 Q1	$2K	Hold	50	–	–	﹤0.01%	327
2019 Q4	$6K	Hold	50	–	–	﹤0.01%	308
2019 Q3	$2K	Hold	50	–	–	﹤0.01%	344
2019 Q2	$2K	Hold	50	–	–	﹤0.01%	349
2019 Q1	$3K	Hold	50	–	–	﹤0.01%	344
2018 Q4	$1K	Buy	+50	New	+$1.96K	﹤0.01%	391

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hartford Financial Management's MTNB Position: Q1 2024 in Review

Hartford Financial Management sold out of Matinas BioPharma (MTNB) in Q1 2024, closing a stake of 50 shares — an estimated $541 sold.

Hartford Financial Management first reported a position in MTNB in Q4 2018 and held it in 21 quarters. The position peaked at $6K in Q4 2019. 42 funds tracked by Wall St. Rank hold MTNB as of Q1 2024.

Hartford Financial Management reported no remaining Matinas BioPharma position as of Q1 2024 after selling out during the quarter.
Hartford Financial Management sold 50 Matinas BioPharma shares in Q1 2024, an estimated $541.
Hartford Financial Management first reported a position in Matinas BioPharma in Q4 2018 and held it in 21 quarters.
Hartford Financial Management's Matinas BioPharma position peaked at $6K in Q4 2019.
42 funds tracked by Wall St. Rank held Matinas BioPharma as of Q1 2024.

Based on Hartford Financial Management's 13F filing for Q1 2024, filed 24 Apr 2024.